Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

541.89
+60.4212.55%
Post-market: 541.890.00000.00%18:07 EDT
Volume:3.34M
Turnover:1.79B
Market Cap:23.24B
PE:19.39
High:557.37
Open:482.20
Low:475.46
Close:481.47
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:6.52
T/O Rate:8.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.63
PE(LYR):19.45

Loading ...

United Therapeutics CEO Martine A. Rothblatt Disposes of Shares Worth $4,287,172.85

Reuters
·
1 hour ago

Top Midday Decliners

MT Newswires Live
·
3 hours ago

RBC Capital Remains a Buy on United Therapeutics (UTHR)

TIPRANKS
·
3 hours ago

Liquidia Found to Infringe United Therapeutics Patent in Court Ruling

MT Newswires Live
·
4 hours ago

Patent ruling ‘a meaningful positive’ for United Therapeutics, says RBC Capital

TIPRANKS
·
4 hours ago

United Therapeutics on Pace for Largest Percent Increase Since September 2025

Dow Jones
·
4 hours ago

Liquidia says court ruled two of six ‘327 patent claims infringed by company

TIPRANKS
·
4 hours ago

Liquidia Corporation - Uthr Requests Injunctive Relief to Restrict Yutrepia Market Availability

THOMSON REUTERS
·
5 hours ago

Liquidia Corporation: "Respectfully Disagree with Court's Decision Regarding Claims 1 and 14"

THOMSON REUTERS
·
5 hours ago

Liquidia Corporation - Parties to Submit Form of Judgment Specifying Remedy Within One Week

THOMSON REUTERS
·
5 hours ago

Liquidia ruling has positive read-through for MannKind Tyvaso DPI, says Truist

TIPRANKS
·
5 hours ago

United Therapeutics Gets Legal Win in Patent Litigation Against Liquidia

Dow Jones
·
5 hours ago

United Therapeutics Shares up 12.2% After Co Wins Court Ruling Against Liquidia

THOMSON REUTERS
·
5 hours ago

Judge upholds claims 1, 14 of United Therapeutics’ ‘327 patent

TIPRANKS
·
6 hours ago

United Therapeutics Corp Stock (UTHR) Moved Up by 12.20% on Sep 30: Key Drivers Unveiled

TradingKey
·
6 hours ago

United Therapeutics up 13% to $543.85 following Liquidia patent ruling

TIPRANKS
·
6 hours ago

United Therapeutics rises 13.2%

TIPRANKS
·
6 hours ago

Movement Alert|United Therapeutics Rises 11.53% in Regular Trading, Multiple Catalysts Including FDA Filings and Share Buyback Drive Largest Gain Since March

Market Focus
·
Yesterday

United Therapeutics Chairperson, CEO Martine Rothblatt Reports UTHR Common Share Disposal Worth $4.61 Million

Reuters
·
Sep 29

United Therapeutics Downgraded to Sell as Premium Valuation Clashes with Shrinking Core Business and Challenging Launch Outlook for Tyvaso and Jenraldi

TIPRANKS
·
Sep 25